200 related articles for article (PubMed ID: 2243677)
1. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
[TBL] [Abstract][Full Text] [Related]
2. The effect of pre-enucleation radiotherapy on mitotic activity of choroidal and ciliary body melanomas.
Augsburger JJ; Eagle RC; Chiu M; Shields JA
Ophthalmology; 1987 Dec; 94(12):1627-30. PubMed ID: 3431833
[TBL] [Abstract][Full Text] [Related]
3. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
Pe'er J; Gnessin H; Shargal Y; Livni N
Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
[TBL] [Abstract][Full Text] [Related]
4. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous expression of melanoma-associated antigens in uveal melanomas.
van der Pol JP; Jager MJ; de Wolff-Rouendaal D; Ringens PJ; Vennegoor C; Ruiter DJ
Curr Eye Res; 1987 Jun; 6(6):757-65. PubMed ID: 3608565
[TBL] [Abstract][Full Text] [Related]
8. Effect of pre-enucleation radiotherapy on the viability of human choroidal melanoma cells.
Rousseau AP; Deschênes J; Pelletier G; Tremblay M; Larochelle-Belland M
Can J Ophthalmol; 1989 Feb; 24(1):10-4. PubMed ID: 2713751
[TBL] [Abstract][Full Text] [Related]
9. Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma.
Corrêa ZM; Augsburger JJ; Freire J; Eagle RC
Arch Ophthalmol; 1999 Feb; 117(2):259-61. PubMed ID: 10037576
[TBL] [Abstract][Full Text] [Related]
10. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
[TBL] [Abstract][Full Text] [Related]
11. Intraocular collision tumour: case report and literature review.
Coupland SE; Dodson A; Liu H; Du MQ; Angi M; Damato BE
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1383-8. PubMed ID: 23232651
[TBL] [Abstract][Full Text] [Related]
12. Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes.
Seddon JM; Gragoudas ES; Albert DM
Arch Ophthalmol; 1983 Sep; 101(9):1402-8. PubMed ID: 6311146
[TBL] [Abstract][Full Text] [Related]
13. Human uveal melanoma expresses NG2 immunoreactivity.
Li Y; Madigan MC; Lai K; Conway RM; Billson FA; Crouch R; Allen BJ
Br J Ophthalmol; 2003 May; 87(5):629-32. PubMed ID: 12714409
[TBL] [Abstract][Full Text] [Related]
14. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
15. DNA cell cycle studies in uveal melanoma.
Char DH
Trans Am Ophthalmol Soc; 1988; 86():561-80. PubMed ID: 2979030
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the tumor regression rate of 127 uveal melanomas irradiated with 106 Ru/106 Rh. Attempted analysis of the correlations between per-operative cytology and histopathology of the enucleated eye and the tumoral regression on the one hand, and general prognosis on the other hand].
Grange JD; Thacoor S; Bievelez B; Jean-Louis B; Baute B; Gérard JP; Sentenac I; Fontanière B; Bailly C
Ophtalmologie; 1990; 4(3):221-4. PubMed ID: 2250951
[TBL] [Abstract][Full Text] [Related]
17. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
18. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
19. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
20. Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas.
Toivonen P; Mäkitie T; Kujala E; Kivelä T
Curr Eye Res; 2003 Oct; 27(4):237-45. PubMed ID: 14562175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
